Zafar Aziz
Deutsche Bank Aktiengesellschaft

Hello, and welcome to the 30th Deutsche Bank Depository Receipts Virtual Investor Conference, dbVIC. My name is Zaf Aziz from the DR Investor Relations Advisory Team at Deutsche Bank. I'm pleased to announce that our next presentation will be from Belite Bio.

Before handing over to our presenter, some points to note. Please submit your questions at any time throughout the presentation. Finally, all of our presentations will be recorded and can be access by the Deutsche Bank website, adr.db.com.

At this point, I'm very pleased to welcome our speaker from Belite Bio.

Hendrik Scholl
Chief Medical Officer

Thank you. Hello. I would like to welcome everybody to the presentation of Belite Bio. I just have to share my screen, here we are. All right. And I hope my screen can be seen.

The title of my talk is early intervention with an oral treatment for macular degeneration. This is our forward-looking statement and legal disclaimer. My name is Hendrik Scholl. I'm the Chief Medical Officer of Belite Bio, and I must say that I can't see my slides here on the screen. I can't see -- are my slides being shown?

Unknown Attendee

Yes, right now, I see the management team. Now the pipeline.

Hendrik Scholl
Chief Medical Officer

Okay. So we see -- so what you see right now? You see the Belite Bio executive team?

Unknown Attendee

Yes. And now disclaimer.

Hendrik Scholl
Chief Medical Officer

Okay. So my name is Hendrik Scholl. I'm the Chief Medical Officer of Belite Bio. I'm a retinal specialist by training. Started my